- Home
- ARGX vs CTVA Comparison
ARGX vs CTVA Comparison
Compare ARGX & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- CTVA
- Stock Information
- Founded
- ARGX 2008
- CTVA 2018
- Country
- ARGX Netherlands
- CTVA United States
- Employees
- ARGX N/A
- CTVA N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- CTVA Farming/Seeds/Milling
- Sector
- ARGX Health Care
- CTVA Consumer Staples
- Exchange
- ARGX Nasdaq
- CTVA Nasdaq
- Market Cap
- ARGX 37.3B
- CTVA 44.1B
- IPO Year
- ARGX 2017
- CTVA N/A
- Fundamental
- Price
- ARGX $623.82
- CTVA $57.48
- Analyst Decision
- ARGX Strong Buy
- CTVA Buy
- Analyst Count
- ARGX 20
- CTVA 18
- Target Price
- ARGX $634.50
- CTVA $65.31
- AVG Volume (30 Days)
- ARGX 290.3K
- CTVA 4.0M
- Earning Date
- ARGX 10-31-2024
- CTVA 02-05-2025
- Dividend Yield
- ARGX N/A
- CTVA 1.18%
- EPS Growth
- ARGX N/A
- CTVA N/A
- EPS
- ARGX N/A
- CTVA 0.98
- Revenue
- ARGX $1,908,659,000.00
- CTVA $16,637,000,000.00
- Revenue This Year
- ARGX $61.99
- CTVA $0.62
- Revenue Next Year
- ARGX $42.48
- CTVA $2.34
- P/E Ratio
- ARGX N/A
- CTVA $60.71
- Revenue Growth
- ARGX 85.56
- CTVA N/A
- 52 Week Low
- ARGX $349.86
- CTVA $44.01
- 52 Week High
- ARGX $644.97
- CTVA $64.20
- Technical
- Relative Strength Index (RSI)
- ARGX 58.04
- CTVA 41.04
- Support Level
- ARGX $613.95
- CTVA $56.16
- Resistance Level
- ARGX $644.97
- CTVA $60.10
- Average True Range (ATR)
- ARGX 14.33
- CTVA 1.25
- MACD
- ARGX -0.42
- CTVA -0.48
- Stochastic Oscillator
- ARGX 50.28
- CTVA 20.85
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.